Topics
Gliomas | Treatment | Immunotherapy | Overview
Home > Publications > Topics > Gliomas > Treatment > Immunotherapy > Overview
*Zhou Y, Liu M, Huang X, Liu Z, Sun
Y, Wang M, Huang T, Wang X, Chen L, Jiang X.
Emerging
trends and thematic evolution of immunotherapy for glioma based on
the top 100 cited articles.
Front
Oncol. 2024 Jan
12;13:1307924. doi:
10.3389/fonc.2023.1307924. PMID:
38293697. Bibliometric analysis. ˍ
*Xing Y, Yasinjan F, Geng H, He M, Yang M, Gao Y, Zhang J, Zhang
L, Guo B.
A scientometric analysis of
immunotherapies for gliomas: Focus on GBM.
Asian
J Surg. 2024 Mar 5:S1015-9584(24)00400-7. doi:
10.1016/j.asjsur.2024.02.138. PMID:
38448290. Bibliometric analysis. ˍ
Meng X, Tian L, Cai J.
Editorial:
Insights and implications of mechanisms shaping glioma immune
landscape, immunotherapy resistance, and relevant translational
research.
Front
Oncol. 2024 Sep 26;14:1485761. doi:
10.3389/fonc.2024.1485761. PMID:
39391240. Editorial. ˍ
Sarantopoulos A, Ene C, Aquilanti E.
Therapeutic
approaches to modulate the immune
microenvironment in gliomas.
NPJ
Precis Oncol. 2024 Oct 23;8(1):241. doi:
10.1038/s41698-024-00717-4. PMID:
39443641. Review. ˍ